KRAS and neoplasm: There was a strong correlation between the percentage of KRAS p.G12D mutations determined in tumor DNA samples by the two methods, with a Spearman’s rho of 0.666 (p < 0.001) and 0.670 (p < 0.001) when %mutation of >0% and >0.1% were considered for a positive reaction in dPCR, respectively (Figure 3).